This is a preview of subscription content, log in via an institution to check access.
Reference
Desar IME, et al. Optimizing the dose in patients treated with imatinib as first line treatment for gastrointestinal stromal tumors: A cost-effectiveness study. British Journal of Clinical Pharmacology : 12 May 2019. Available from: URL: http://doi.org/10.1111/bcp.13990
Rights and permissions
About this article
Cite this article
Drug monitoring optimises imatinib dosing cost effectively. PharmacoEcon Outcomes News 829, 9 (2019). https://doi.org/10.1007/s40274-019-5923-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5923-5